DE69823411T2 - 2-Aminoidan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen - Google Patents

2-Aminoidan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen Download PDF

Info

Publication number
DE69823411T2
DE69823411T2 DE69823411T DE69823411T DE69823411T2 DE 69823411 T2 DE69823411 T2 DE 69823411T2 DE 69823411 T DE69823411 T DE 69823411T DE 69823411 T DE69823411 T DE 69823411T DE 69823411 T2 DE69823411 T2 DE 69823411T2
Authority
DE
Germany
Prior art keywords
amino
piperidine
indan
fumarate
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69823411T
Other languages
German (de)
English (en)
Other versions
DE69823411D1 (de
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of DE69823411D1 publication Critical patent/DE69823411D1/de
Publication of DE69823411T2 publication Critical patent/DE69823411T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69823411T 1997-02-27 1998-02-27 2-Aminoidan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen Expired - Fee Related DE69823411T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR9702360 1997-02-27

Publications (2)

Publication Number Publication Date
DE69823411D1 DE69823411D1 (de) 2004-06-03
DE69823411T2 true DE69823411T2 (de) 2005-02-17

Family

ID=9504253

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69823411T Expired - Fee Related DE69823411T2 (de) 1997-02-27 1998-02-27 2-Aminoidan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen

Country Status (18)

Country Link
US (1) US5968954A (enExample)
EP (1) EP0861837B1 (enExample)
JP (1) JPH10237071A (enExample)
CN (1) CN1090627C (enExample)
AT (1) ATE265451T1 (enExample)
AU (1) AU725756B2 (enExample)
BR (1) BR9800763A (enExample)
CA (1) CA2231025C (enExample)
DE (1) DE69823411T2 (enExample)
DK (1) DK0861837T3 (enExample)
ES (1) ES2219853T3 (enExample)
FR (1) FR2760014B1 (enExample)
HU (1) HU224312B1 (enExample)
NO (1) NO314307B1 (enExample)
NZ (1) NZ329853A (enExample)
PL (1) PL190240B1 (enExample)
PT (1) PT861837E (enExample)
ZA (1) ZA981680B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI274750B (en) * 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
KR100864356B1 (ko) * 2001-01-16 2008-10-17 아스트라제네카 아베 치료용 헤테로시클릭 화합물
DE60231507D1 (de) 2001-07-20 2010-07-01 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
WO2006062063A1 (ja) * 2004-12-08 2006-06-15 Astellas Pharma Inc. ピペリジン誘導体及びその製造法
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CN1194983A (zh) 1998-10-07
NZ329853A (en) 1999-01-28
JPH10237071A (ja) 1998-09-08
DE69823411D1 (de) 2004-06-03
AU725756B2 (en) 2000-10-19
EP0861837B1 (fr) 2004-04-28
FR2760014B1 (fr) 1999-04-09
PT861837E (pt) 2004-07-30
HU224312B1 (hu) 2005-07-28
ES2219853T3 (es) 2004-12-01
HK1014945A1 (en) 1999-10-08
HUP9800422A1 (hu) 1999-12-28
PL324982A1 (en) 1998-08-31
CA2231025C (fr) 2003-09-16
HU9800422D0 (en) 1998-04-28
ZA981680B (en) 1998-09-04
AU5635998A (en) 1998-09-03
NO980803L (no) 1998-08-28
DK0861837T3 (da) 2004-08-16
BR9800763A (pt) 1999-12-07
CA2231025A1 (fr) 1998-08-27
PL190240B1 (pl) 2005-11-30
FR2760014A1 (fr) 1998-08-28
EP0861837A1 (fr) 1998-09-02
CN1090627C (zh) 2002-09-11
ATE265451T1 (de) 2004-05-15
NO314307B1 (no) 2003-03-03
US5968954A (en) 1999-10-19
NO980803D0 (no) 1998-02-26

Similar Documents

Publication Publication Date Title
DE69824332T2 (de) N-Aryl-piperidinderivate und ihre Verwendung als 5-HT1B-Rezeptorliganden
DE69614608T2 (de) Piperazin-, Piperidin- und 1,2,5,6-Tetrahydropyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69323630T2 (de) Benzokondensierte verbindungen
DE69427704T2 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
DE69411939T2 (de) Kondensierte pyrrolcarboxanilide; eine neue klasse von gaba-gehirn-rezeptor-liganden
DE60009663T2 (de) Piperidin-, tetrahydropyridin- und piperazin-derivate, ihre herstellung und anwendung
DE69532162T2 (de) Cannabinoid-rezeptor-antagonisten
DE69728768T2 (de) 2,4-diaminopyrimidine derivates als dopamine d4 rezeptorantagonisten
DE69819173T2 (de) Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung
DE60018274T2 (de) Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
DE69735647T2 (de) Kondensierte pyrrolcarboxamide; eine neue klasse von gabe-gehirn-rezeptoren-liganden
DE69101067T2 (de) Aminomethylpiperidinderivate, deren Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE69823411T2 (de) 2-Aminoidan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DE69519047T2 (de) Benzodioxan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DE68910451T2 (de) 1,4-benzoxazin- und 1,4-benzothiazin-derivate und verfahren zu deren herstellung.
DE60219687T2 (de) Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
DE60207857T2 (de) Neue heteroarylderivate, deren herstellung und verwendung
DE69936572T2 (de) Benzisoxazolderivate mit d4-antagonistischer wirkung
DE69810560T2 (de) Indanol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69102477T2 (de) 3-Aminochroman-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE69900961T2 (de) Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DE602004012724T2 (de) 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridinderivaten zur verwendung als serotonin-wiederaufnahmehemmer
DE69706813T2 (de) 4-Hydroxypiperidinderivate
DE69518322T2 (de) C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel
DE60013716T2 (de) Tetrahydrochinazolin-2,4-dione zur Verwendung als therapeutische Medikamente

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee